Autoimmune diseases are a challenge for modern medicine, affecting various organs and systems. Rank_math_focus_keyword plays a key role in the development and treatment of these diseases. Awareness of the mechanisms of autoimmunity facilitates effective diagnosis and modern therapy.
Table of Contents
- What are autoimmune diseases?
- Typical symptoms and diagnosis
- Mechanisms of autoimmunity in the body
- Impact on different organs and symptoms
- The role of the gut in autoimmunity
- Modern treatment methods
What are autoimmune diseases?
Autoimmune diseases are a group of disorders in which the immune system – instead of protecting the body against microorganisms such as bacteria, viruses, or fungi – mistakenly identifies its own cells and tissues as the enemy and starts attacking them. In a healthy body, the immune system acts as a guardian: it identifies foreign molecules (antigens), produces antibodies, and activates defense cells to neutralize them. Here, the phenomenon of so-called immune tolerance is key – the ability to distinguish ‘self’ from ‘non-self.’ In autoimmune diseases, this delicate balance is disrupted – tolerance to one’s own tissues disappears, autoantibodies (antibodies directed against elements of the body) and excessively stimulated T and B lymphocytes appear, initiating a chronic inflammatory state. The attack can affect almost any part of the body: joints, muscles, skin, endocrine glands (e.g., thyroid, pancreas), intestines, kidneys, blood vessels, and even blood cells or nervous system structures. Importantly, autoimmune diseases do not constitute a uniform entity but a broad and diverse category, encompassing both organ-specific diseases (primarily attacking one organ, e.g., Hashimoto’s autoimmune thyroiditis), as well as systemic diseases, such as systemic lupus erythematosus, rheumatoid arthritis, or scleroderma, where the inflammatory process involves many different organs and tissues simultaneously. As a result, the symptoms of these disorders are exceptionally diverse – from local pain or skin rashes to general weakness, chronic fatigue, fever, internal organ dysfunction, and life-threatening complications.
Unlike infections, which usually have a clear cause (a specific pathogen) and often resolve after treatment, autoimmune diseases have a chronic, multifactorial character and are generally not completely curable – however, effective control and alleviation of symptoms are possible. The development of autoimmunity is due to a complicated combination of genetic predisposition, environmental factors, and immune regulation disorders. We inherit a certain ‘tendency’ towards autoimmunity (e.g., specific HLA gene variants), but the mere presence of these genes does not determine disease. Usually, the action of additional stimuli is required: chronic stress, viral or bacterial infections, hormonal disorders (partially explaining why autoimmune diseases affect women more often), smoking, environmental toxin exposure, or tissue damage. Autoimmune diseases are often said to be ‘masters of disguise’ in medicine: they can mimic many other diseases, cause nonspecific symptoms (such as chronic fatigue, muscle and joint pain, mood swings, weight loss or, on the contrary – weight gain), which makes the diagnostic path long and bumpy. Another challenge is that the autoimmune process can silently progress for years before a full-blown disease appears; some autoantibodies can be detected in the blood long before symptoms appear. To understand what autoimmune diseases are, it is worth looking at them not just as a list of disease names, but primarily as a shared mechanism – a misprogrammed immune system that, instead of defending, begins to destroy. This requires a different therapeutic approach: the goal of treatment is not so much to fight an external enemy, but to suppress excessive immune reactivity, limit inflammation, and protect tissues from further damage. Understanding the nature of these diseases facilitates early recognition of warning signs, acceptance of the need for long-term therapy, and conscious cooperation with the doctor in the treatment process and lifestyle modification, which is crucial for the prognosis and quality of daily functioning of people struggling with autoimmunity.
Typical symptoms and diagnosis
The clinical picture of autoimmune diseases is extremely diverse, but there are several recurring patterns that should raise concern. The most common, rather nonspecific but very characteristic symptoms of autoimmunity include chronic fatigue that persists despite rest, weakness, and a feeling of being ‘run down,’ often mistaken for overwork or stress. Many people experience recurrent low-grade or full fevers without a clear infectious cause, unintended weight loss, or, conversely, sudden weight gain related to hormonal disturbances, as in autoimmune thyroiditis. Joint and muscle pain, morning stiffness lasting over 30 minutes, joint swelling, as well as redness and a feeling of warmth in the affected area are common. In some patients, skin symptoms dominate: rashes, depigmentation or discoloration patches, the characteristic butterfly rash on the face in systemic lupus, excessive hair loss, brittle nails, or chronic, hard-to-heal skin lesions. Very bothersome and often ignored signals include dryness of mucous membranes (eyes, mouth, genital organs) typical, for example, of Sjögren’s syndrome, recurrent mouth ulcers, gastrointestinal disturbances – diarrhea, bloating, abdominal pain, blood in stools as in Crohn’s disease or ulcerative colitis – as well as mood swings, concentration problems, and so-called ‘brain fog’. In some patients, organ symptoms prevail: arrhythmias, shortness of breath, decreased exercise tolerance, neurological symptoms such as numbness, tingling of limbs, visual disturbances, sudden muscle weakness, or coordination problems that may suggest multiple sclerosis or other inflammatory diseases of the central nervous system. It is also characteristic that the symptoms often have a fluctuating course – periods of exacerbation intermingle with remission, when the patient feels relatively well, which further hinders early recognition. An important clue for the doctor is also the co-occurrence of many seemingly unrelated ailments, such as the combination of intestinal problems, skin changes, and joint pain, as well as the presence of autoimmune diseases in the family, which increases the risk of genetic predisposition. Symptoms worsening after infections, stress, or sun exposure, which can ‘trigger’ immune activation and intensify autoimmunity, are also emphasized.
The diagnostic process for autoimmune diseases requires a comprehensive approach and collaboration of various specialists, such as rheumatologists, endocrinologists, gastroenterologists, dermatologists, or neurologists. The first stage is a detailed medical interview, during which the doctor asks about the type and duration of symptoms, their intensity, triggering factors, occurrence of similar diseases in the family, as well as past illnesses, lifestyle, and medications taken. Then a thorough physical examination is performed, assessing, among others, joints, skin, mucous membranes, thyroid, lymph nodes, pulse, blood pressure, and potential neurological symptoms. Laboratory tests are crucial: basic ones, such as CBC, ESR, CRP, liver function tests, kidney parameters, thyroid profile (TSH, FT3, FT4), glucose or electrolytes, as well as more specialized tests, including antibody detection specific for autoimmune diseases. Examples are antinuclear antibodies ANA and their subtypes (e.g., anti-dsDNA, anti-Sm in lupus, anti-SSA/SSB in Sjögren’s syndrome), antibodies to the TSH receptor (in Graves’ disease), anti-TPO and anti-TG (in Hashimoto’s autoimmune thyroiditis), anti-neutrophil cytoplasmic antibodies ANCA (in vasculitis), anti-CCP and rheumatoid factor RF (in rheumatoid arthritis), or anti-tissue transglutaminase and endomysium antibodies (in celiac disease). Supplementary tests include imaging – thyroid ultrasound, abdominal ultrasound, joint ultrasound, brain and spinal MRI, CT scan, X-ray of joints or chest – which allow assessment of tissue damage and the severity of inflammation. In many cases, functional tests (e.g., spirometry, nerve conduction tests, stress tests) and tissue biopsies: skin, synovial membrane, intestine, thyroid, kidney or salivary glands, are required to confirm the characteristic histopathological picture of autoimmune inflammation. Due to the variable course of diseases, a single negative result does not always exclude autoimmunity – tests often need to be repeated over time, and the diagnosis relies on the combination of clinical, laboratory, and imaging criteria. Increasingly, early diagnostics are used in risk groups, such as testing for antibodies in people with a positive family history or coexisting autoimmune diseases, which can detect the process before irreparable organ damage occurs. Patient observation and conscious self-monitoring are also extremely important – keeping track of new symptoms, their relation to circadian rhythm, diet, stress, or infections helps the doctor make a more accurate diagnosis and select the most appropriate tests and later treatment.
Mechanisms of autoimmunity in the body
Although externally autoimmune diseases present relatively non-specifically, internally they involve extremely complex biological processes that cause the immune system to perceive its own tissues as an enemy. The key concept is the loss of immune tolerance, that is, the mechanisms by which lymphocytes learn to recognize ‘self’ structures and not react to them with aggression. In a normally functioning body, immune cells undergo so-called central selection in the thymus (T lymphocytes) and bone marrow (B lymphocytes), where those reacting strongly to own antigens are eliminated. Some ‘potentially dangerous’ cells escape this control and are regulated peripherally – through regulatory cells (e.g., Treg lymphocytes), inhibitory response molecules (CTLA-4, PD-1), and a complex network of biochemical signals. Autoimmunity develops when these oversight systems fail or are chronically overloaded. These mechanisms can be likened to a multi-level security system – if the filter at the lymphocyte ‘production’ stage fails and then the safety brakes at the periphery do not work, the body is left unprotected against its own rebellious immune army. In many autoimmune diseases, molecular mimicry serves as the trigger. This occurs when structures of microorganisms (viruses, bacteria) resemble the body’s own proteins. During infection, the immune system correctly produces antibodies and cells against the pathogen, but the same cells and antibodies ‘get confused’ and cross-react with similar elements of the host’s tissues. A classic example is reactive arthritis or the link between streptococcal infection and rheumatic fever, but a similar scheme is suspected in many other autoimmune diseases, including type 1 diabetes. Another often discussed mechanism is so-called epitope spreading – a process in which an initially limited response to one antigen fragment gradually extends to other parts of the same molecule or even different proteins in the same tissue. As a result, the autoimmune response becomes increasingly extensive and harder to control. Changes in antigen presentation by antigen-presenting cells (APC), such as dendritic cells, are also fundamentally important – when, under chronic inflammation or environmental influences, they present self antigens in an ‘inflammatory context,’ they signal to lymphocytes that these are threats and should be attacked.
The genetic and epigenetic background – not just the genes themselves but also how they are regulated – also plays a vital role in the development of autoimmunity. Certain variants of genes encoding HLA molecules, lymphocyte receptors, cytokines or proteins involved in immune signaling predispose to a more intense or poorly controlled response. However, genetics do not ‘doom’ one to disease, but only increase susceptibility, which usually activates only upon relevant environmental triggers. These include infections, chronic stress, smoking, obesity, hormonal disorders, medications, as well as factors damaging the intestinal or skin barrier. Damage to biological barriers promotes ‘leakage’ of antigens and enhanced presentation of structures that normally remain hidden from the immune system, which may initiate or maintain an autoimmune response. Increasing significance is ascribed to the gut microbiota – its composition influences lymphocyte maturation, the balance between effector (pro-inflammatory) and regulatory cells, and the production of metabolites (e.g., short-chain fatty acids), which may have anti-inflammatory or pro-inflammatory effects. Microbiota disorders (dysbiosis) are observed in rheumatoid arthritis, inflammatory bowel disease, and lupus, suggesting that mechanisms of autoimmunity result from a complex interaction between gut bacteria and the host immune system. The role of cytokines – proteins responsible for communication between immune cells – deserves attention. In autoimmune diseases, overproduction of pro-inflammatory cytokines such as TNF-α, IL-6, IL-17, or type I interferons is observed, driving a vicious circle of inflammation: activating more lymphocytes, increasing the expression of antigen-presenting molecules, facilitating infiltration of cells into tissues, and intensifying tissue damage. For this reason, many modern biological therapies target these pathways – by blocking specific cytokines, receptors, or immune checkpoints, doctors aim to ‘break’ the mechanism of autoimmunity without completely suppressing the body’s ability to defend against real pathogens. Autoimmunity rarely results from a single factor; usually it is the effect of overlapping lymphocyte selection disorders, regulatory cell defects, improper antigen presentation, genetic and environmental factors, and persistent chronic inflammation that changes immune cell behavior and teaches them ‘bad habits’ in recognizing one’s own tissues.
Impact on different organs and symptoms
Autoimmune diseases can attack virtually every organ and tissue in the body, which is why their clinical picture is extremely diverse. In many cases, we are dealing with organ-specific diseases focusing on one system (e.g., autoimmune thyroiditis, type 1 diabetes), but there are also systemic diseases affecting numerous structures simultaneously (e.g., systemic lupus erythematosus, rheumatoid arthritis). The musculoskeletal system is one of the most frequently affected – chronic joint inflammation leads to pain, swelling, morning stiffness, and gradual destruction of cartilage and bone, resulting in limited mobility and deformities. Joint symptoms may be symmetrical, as in rheumatoid arthritis, or asymmetrical, mainly involving the spine and sacroiliac joints, as in spondyloarthropathies. Muscles can also be targeted by autoimmunity – inflammatory myopathies manifest as progressive weakness, difficulty climbing stairs, raising arms, or getting up from a seated position. A wide spectrum of skin changes is seen: from butterfly erythema in lupus, through scaly plaques in psoriasis, to blisters in pemphigoid and pemphigus, and depigmentation in vitiligo. These changes often worsen under the influence of UV radiation, infections, or stress, and their visibility on exposed body parts may significantly impact self-esteem and social relationships. The endocrine system is another key domain – in Hashimoto’s disease, the thyroid is progressively destroyed, resulting in hypothyroidism, manifested by feelings of cold, weight gain, drowsiness, and psychomotor slowing, while in Graves’ disease, hyperthyroidism causes palpitations, weight loss despite appetite, irritability, and characteristic eye bulging. In type 1 diabetes, caused by autoimmune destruction of pancreatic β cells, main symptoms are increased thirst, frequent urination, weight loss, and susceptibility to ketoacidosis, which can be life-threatening without treatment.
Significant effects of autoimmune diseases are also observed within the digestive, nervous, and hematopoietic systems. In celiac disease, the immune reaction to gluten damages intestinal villi, causing diarrhea, bloating, vitamin and mineral deficiencies, and, for some, the only sign may be skin changes or chronic fatigue. In inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, abdominal pain, diarrhea (often with blood), weight loss, and low-grade fevers dominate, with inflammation possibly affecting the digestive tract from mouth to anus, causing fistulas and strictures. The nervous system can be a direct target (e.g., in multiple sclerosis, where demyelination of nerve fibers occurs) or secondarily affected by vasculitic inflammatory processes. Neurological symptoms vary: from limb numbness, vision and balance disorders, to muscle weakness, seizures, or cognitive impairment. In myasthenia, autoimmune antibodies against acetylcholine receptors at the neuromuscular junction cause muscle fatigability – patients experience drooping eyelids, double vision, chewing, swallowing, and speech difficulties, and in severe cases, even respiratory failure. The hematopoietic system is the site for autoimmune hemolytic anemia or immune thrombocytopenia – symptoms include pallor, weakness, tendency to bruising, nose and gum bleeding, as well as petechiae on the skin. In systemic diseases such as lupus, scleroderma, or vasculitis, multi-organ involvement occurs – heart (pericarditis, arrhythmias), lungs (fibrosis, pulmonary hypertension), kidneys (glomerulonephritis with proteinuria and hypertension), potentially leading to chronic organ failure. A common thread is the presence of so-called general symptoms: chronic fatigue, subfebrile states or fever, weight loss, night sweats, and mood lowering. Their severity often correlates with disease activity and appears in flares interspersed with periods of relative calm. This fluctuating course means patients sometimes spend years seeking the cause of their ailments, consulting many specialists before linking scattered symptoms (skin, joint, digestive, neurological) into a common picture of an autoimmune disease. The more organs involved, the more complex diagnosis and treatment become, and somatic symptoms begin to intertwine with psychological and social consequences, affecting all areas of daily life.
The role of the gut in autoimmunity
The gut plays a key role in the development and maintenance of autoimmune diseases, as it is one of the most important ‘training grounds’ for the immune system. Here, as much as 70–80% of the body’s immune cells are located, which must daily determine whether contact with food, bacteria, and other molecules is safe or a potential threat. The intestinal barrier, composed of epithelial cells, tight junctions between them, and protective mucus, acts as an intelligent filter – letting nutrients through but blocking toxins and pathogens. When this barrier is damaged, so-called increased intestinal permeability (‘leaky gut’) occurs, promoting the passage of large protein molecules, bacterial cell wall fragments, or toxins into the bloodstream. The immune system then overreacts, producing antibodies and inflammatory mediators that may eventually ‘confuse’ and direct the response against its own tissues. This process is particularly significant in diseases such as celiac disease, inflammatory bowel disease, rheumatoid arthritis, or thyroid diseases, where intestinal barrier disturbances are observed much more frequently than in healthy individuals. At the same time, the mucous membranes of the intestines have an educational function for lymphocytes – through contact with harmless dietary antigens and ‘good’ microorganisms, they teach them tolerance, i.e., the ability to ignore triggers that are not a real threat. If this learning process is disrupted (e.g., by infections, antibiotic therapy, a low-fiber diet), the risk of excessive and autoaggressive responses increases.
The second pillar of the gut’s influence on autoimmunity is the microbiota – the vast community of bacteria, viruses, and fungi inhabiting the digestive tract. The composition of this community regulates the maturation of the immune system, the production of short-chain fatty acids (such as butyrate), vitamins, and anti-inflammatory compounds, as well as determining whether a pro-inflammatory or protective environment will dominate. The balance of the microbiota (eubiosis) favors the integrity of the intestinal barrier, the activity of regulatory lymphocytes (Tregs), and the inhibition of excessive production of pro-inflammatory cytokines such as TNF-α or IL-6. When dysbiosis (altered microbiota composition) occurs (e.g., due to chronic stress, excess sugar and saturated fats in the diet, overuse of medications and frequent antibiotic therapy), more bacteria appear in the intestines that produce toxins and pro-inflammatory factors. This, in turn, increases inflammation, perpetuates intestinal leakage, and drives the vicious circle of autoimmunity. More and more research shows that patients with systemic lupus erythematosus, multiple sclerosis, type 1 diabetes, or autoimmune thyroid diseases have characteristic patterns of dysbiosis, and modifying the microbiota (with diet, probiotics, prebiotics) can affect the course of the disease. The gut also communicates with the brain and other organs via the gut–brain–immune axis. Cytokines produced in the intestinal wall, bacterial metabolites, and vagus nerve signals act not only locally but also systemically, regulating mood, stress level, appetite, and the body’s overall inflammatory status. Chronic psychological stress intensifies dysbiosis and increases intestinal permeability, further boosting autoimmunity. For this reason, in treating autoimmune diseases increasing importance is placed on strategies supporting gut health: a diet high in fiber and fermented products, restriction of processed foods, individually tailored probiotic supplementation, as well as work on stress and sleep quality. Restoring gut-immune balance does not replace pharmacotherapy but can support its effectiveness, alleviate symptoms, and reduce the frequency of disease flares by targeting the source of many autoimmunity mechanisms.
Modern treatment methods
Contemporary treatment of autoimmune diseases increasingly relies not just on classic anti-inflammatory drugs and glucocorticosteroids, but also on precise, targeted therapies. The cornerstone remains disease-modifying drugs (DMARDs), such as methotrexate, azathioprine, or mycophenolate mofetil, which suppress excessive immune system activity and slow disease progression. Their task is to reduce inflammation and prevent permanent organ damage, e.g., joints in rheumatoid arthritis or kidneys in systemic lupus erythematosus. Glucocorticosteroids supplement these, most often used chronically at low doses or in so-called pulses during exacerbations, which allow rapid symptom control but require extreme caution due to many side effects (osteoporosis, hypertension, steroid diabetes). Modern therapeutic strategies aim to shorten high-dose steroid use as much as possible and introduce drugs early that enable gradual withdrawal of steroids (so-called ‘steroid-sparing therapy’). Crucial is the ‘treat to target’ approach, where doctors and patients clearly define treatment goals – usually remission or low disease activity – and then regularly monitor clinical and laboratory parameters, dynamically adjusting therapy. Increasing importance is also given to treatment personalization, considering age, comorbidities, pregnancy planning, infection risk, and even individual response to specific drugs, assessed with the help of new biomarkers.
The biggest revolution of the last two decades are modern biological therapies and small molecule drugs, which precisely intervene in selected inflammatory pathways. Biologics – mostly monoclonal antibodies or fusion proteins – block key pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-17, IL-23) or inhibit T and B cell activation (e.g., by blocking co-stimulatory molecules or depleting CD20+ B cells). This enables suppression of autoimmunity while relatively maintaining pathogen defense, although infection risk still remains a significant aspect of therapy. In the treatment of RA, psoriasis, inflammatory bowel disease, or lupus, a wide spectrum of such drugs is currently used, with the choice of preparation depending, among other things, on clinical presentation, prior efficacy of classic therapy, and safety profile. Small molecule JAK inhibitors in tablet form complement these as they modulate intracellular signaling pathways for many cytokines, allowing suppression of a complex inflammatory network across various organs at once. Advanced procedures such as autologous stem cell transplantation are also being developed, used in severe, refractory cases of multiple sclerosis or systemic scleroderma; this procedure ‘resets’ the immune system through intensive chemotherapy and re-administering the patient’s own hematopoietic stem cells. In selected autoimmune diseases, such as severe myasthenia or Guillain-Barré syndrome, plasma exchange and plasmapheresis still play important roles, enabling the rapid removal of circulating autoantibodies. Increasing attention is also paid to lifestyle modification and supportive therapies, which are part of a modern, holistic approach: dietary therapy aimed at supporting gut microbiota and reducing inflammation, vitamin D and omega-3 supplementation, regular, individually adjusted physical activity, and stress reduction techniques (mindfulness, cognitive-behavioral therapy). In clinical practice, drug therapy is combined with patient education, psychological care, and monitoring for side effects, using telemedicine, applications for self-monitoring symptoms, and remote reporting of results. This type of comprehensive, individualized approach is becoming the standard in modern treatment for autoimmune diseases, whose fluctuating course over time requires constant adjustment of therapeutic strategies and close patient cooperation with the medical team.
Summary
Autoimmune diseases are a complex problem in which the immune system attacks its own tissues. Symptoms can affect various organs, such as the skin, joints, or kidneys, and differ in intensity. Multiple factors, including gut health, can influence the development of these diseases. Early detection through symptom observation and proper diagnosis is key, opening the way for effective treatment. The development of modern therapeutic methods offers patients better chances of managing symptoms and improving quality of life. Knowledge of autoimmune diseases and their mechanisms is the first step toward effectively combating these conditions.
